Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 18/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/10

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 11: Figure S11

Description: Differentially abundant between the Naive group and Rifampin treatment group.

Abundance in Group 1: decreased abundance in R (Rifampin)

NCBI	Quality Control	Links
Pseudobutyrivibrio
Butyricicoccus
Acetanaerobacterium
Oxobacter
Sporobacter
Acetivibrio
Blautia
Stomatobaculum
Clostridium
Dorea
Robinsoniella
Tyzzerella
Anaerotruncus
Arthrobacter
Pseudobacteroides
Turicibacter
Ruminococcus
unclassified Romboutsia
Pelotomaculum
Parabacteroides
Erysipelotrichaceae
Alistipes
Akkermansia

Revision editor(s): KateRasheed